Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,100 | -19,550 | -13,010 | -6,600 | -2,380 |
| Depreciation Amortization | 3 | 10 | 10 | 6 | 4 |
| Other Working Capital | 2,650 | 5,570 | 3,520 | 1,470 | 90 |
| Other Operating Activity | 97 | 510 | 440 | 324 | 166 |
| Operating Cash Flow | $-4,350 | $-13,460 | $-9,040 | $-4,800 | $-2,120 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -20 | -20 | -10 | -4 |
| Other Investing Activity | 1,120 | 460 | 1,500 | 640 | 14 |
| Investing Cash Flow | $1,110 | $440 | $1,480 | $630 | $10 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 0 | -820 | -750 | -130 | -60 |
| Other Financing Activity | 1 | 13,650 | 13,640 | 13,650 | 0 |
| Financing Cash Flow | $1 | $12,830 | $12,890 | $13,520 | $-60 |
| Beginning Cash Position | 9,740 | 9,930 | 9,930 | 9,930 | 9,930 |
| End Cash Position | 6,500 | 9,740 | 15,270 | 19,280 | 7,770 |
| Net Cash Flow | $-3,240 | $-190 | $5,330 | $9,340 | $-2,160 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,350 | -13,460 | -9,040 | -4,800 | -2,120 |
| Capital Expenditure | N/A | -24 | N/A | N/A | N/A |
| Free Cash Flow | -4,350 | -13,484 | -9,040 | -4,800 | -2,120 |